2005Journal of Clinical Internal MedicineRequires access

The Effects of Irbesartan and Enalapril in Patients with Essential Hypertension

Fang Wang

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of irbesartan and compare with that of Enalapril in patients from mild to moderate essential hypertension.Methods Patients were randomly assigned to Irbesartan group(n=41),150mg to 300mg/d,or Enalapril group(n=42) 10mg to 20mg/d for 4 and 8 weeks.Results The systolic blood pressure(SBP)and diastolic blood pressure (DBP) decreased significantly in both groups after 2 weeks(P0.01);BP decreased smoothly and continuously during the entire treatment period;The total efficacy rate for decreased DBP after 4 and 8 weeks treatment of Irbesartan were 90.2 %(37/41) and 95.1%(39/41) respectively,that of Enalapril group were 83.3% (35/42)and 90.5% (38/42) respectively,and the difference between 2 group is significant(P0.05).Conclusion Irbesartan is a safe,effective,long acting anti-hypertension drug,tolerable and light side-effect.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of irbesartan and compare with that of Enalapril in patients from mild to moderate essential hypertension.Methods Patients were randomly assigned to Irbesartan group(n=41),150mg to 300mg/d,or Enalapril group(n=42) 10mg to 20mg/d for 4 and 8 weeks.Results The systolic blood pressure(SBP)and diastolic blood pressure (DBP) decreased significantly in both groups after 2 weeks(P0.01);BP decreased smoothly and continuously during the entire treatment period;The total efficacy rate for decreased DBP after 4 and 8 weeks treatment of Irbesartan were 90.2 %(37/41) and 95.1%(39/41) respectively,that of Enalapril group were 83.3% (35/42)and 90.5% (38/42) respectively,and the difference between 2 group is significant(P0.05).Conclusion Irbesartan is a safe,effective,long acting anti-hypertension drug,tolerable and light side-effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of irbesartan and compare with that of Enalapril in patients from mild to moderate essential hypertension.Methods Patients were randomly assigned to Irbesartan group(n=41),150mg to 300mg/d,or Enalapril group(n=42) 10mg to 20mg/d for 4 and 8 weeks.Results The systolic blood pressure(SBP)and diastolic blood pressure (DBP) decreased significantly in both groups after 2 weeks(P0.01);BP decreased smoothly and continuously during the entire treatment period;The total efficacy rate for decreased DBP after 4 and 8 weeks treatment of Irbesartan were 90.2 %(37/41) and 95.1%(39/41) respectively,that of Enalapril group were 83.3% (35/42)and 90.5% (38/42) respectively,and the difference between 2 group is significant(P0.05).Conclusion Irbesartan is a safe,effective,long acting anti-hypertension drug,tolerable and light side-effect.

Key concepts: Irbesartan, Enalapril, Medicine, Blood pressure, Essential hypertension, Internal medicine, Clinical efficacy, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Effects of Irbesartan and Enalapril in Patients with Essential Hypertension — Research Paper | ScholarLens